Mesenchymal stem cell therapy for equine tendinitis
Nenhuma Miniatura disponível
Data
2013-03-28
Autores
Alves, Ana Liz Garcia [UNESP]
de Mattos Carvalho, Armando [UNESP]
Hussni, Carlos Alberto [UNESP]
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Tendinitis is an important disease that leads to lameness and decreased performance in equine athletes and results in high costs associated with therapy due to a long recovery period and a high rate of recurrence. Although, several treatments for equine tendinitis have been described, few are effective in significantly improving the quality of the extracellular matrix and reducing the rate of recurrence. The use of cell therapy with mesenchymal stem cells (MSCs) derived from various sources has received much attention because of its therapeutic potential for equine tendinitis. In this paper, we review patents on stem cell therapy and the specific use of MSCs for the treatment of equine tendinitis. © 2013 Bentham Science Publishers.
Descrição
Palavras-chave
Adipose tissue, Adult stem cells, Bone marrow, Cell therapy, Equine, Tendinitis, 5' nucleotidase, bone morphogenetic protein 12, cell marker, endoglin, scatter factor, somatomedin C, Thy 1 antigen, vasculotropin, apoptosis, bone marrow biopsy, cell adhesion, cell proliferation, cell transdifferentiation, extracellular matrix, gene expression, hematopoietic stem cell, histopathology, horse, human, immunophenotyping, mesenchymal stem cell transplantation, multipotent stem cell, nonhuman, priority journal, recurrence risk, review, sarcoma, tendinitis, tissue engineering, wound healing
Como citar
Recent Patents on Regenerative Medicine, v. 3, n. 2, p. 103-110, 2013.